NCT06947044
- Conditions
- Acute Leukemia, Acute Lymphocytic Leukaemia, Acute Myeloid Leukemia (AML), +16 more
- Locations
-
- Juravinski Hospital Hamilton, Ontario, Canada
Clinical trial condition
Acute Myeloid Leukemia (AML)
Explore clinical trials studying Acute Myeloid Leukemia (AML). Study availability and eligibility vary by location and protocol.
154 public trials
46 recruiting studies
Acute Myeloid Leukemia (AML) trial results
NCT02781883
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- UCLA Medical Center Los Angeles, California, United States
- Georgia Cancer Center at Augusta University Augusta, Georgia, United States
- University of Kansas Cancer Center Fairway, Kansas, United States
- New Jersey Hematology Oncology Associates Brick, New Jersey, United States
NCT06760260
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT06642025
- Conditions
- Acute Myeloid Leukemia (AML), CAR-T, Hematologic Diseases, +6 more
- Locations
-
- The Second Affliated Hospital of Anhui Medical University Hefei, Anhui, China
NCT04275518
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- The First Hospital of Peking University Beijing, Beijing Municipality, China
- Guangzhou panyu central hospital Guangzhou, Guangdong, China
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
- Henan Provincial Oncology Hospital Zhengzhou, Henan, China
NCT06550713
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
- Peking University international Hospital Beijing, Beijing Municipality, China
- The Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China
- Harbin The First Hospital Harbin, Heilongjiang, China
Not yet recruiting
CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid Leukemia
NCT07841002
- Conditions
- Acute Myeloid Leukemia (AML), Cytokine Release Syndrome, Disease Attributes, +16 more
- Locations
-
- Chinese PLA General Hospital, Beijing, Beijing 100853 Beijing, China
Not yet recruiting
Liposomal Mitoxantrone Plus Azacitidine and Venetoclax in Newly Diagnosed Elderly or Unfit AML
NCT07828535
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
Not specified
Not yet recruiting
A Randomized Trial of Venetoclax-Based Induction Intensity in Newly Diagnosed Acute Myeloid Leukemia
NCT07754799
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
Not specified
Not yet recruiting
A Phase 1 Open-Label, Dose-Ranging Safety and Pharmacokinetics Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)
NCT07053020
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States